Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus (Q33925690)

30 July 2017

1 reference

title

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus (English)

1 reference

30 July 2017

1 reference

MacDonald A

1

1 reference

30 July 2017

Scarola J

series ordinal

2

1 reference

30 July 2017

Burke JT

series ordinal

3

1 reference

30 July 2017

Zimmerman JJ

series ordinal

4

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

published in

Clinical Therapeutics

1 reference

30 July 2017

volume

22 Suppl B

1 reference

30 July 2017

page(s)

B101-121

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Sirolimus: a new agent for clinical renal transplantation

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Immunopharmacology of rapamycin

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Rapamycin (sirolimus, rapamune).

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Population pharmacokinetics of sirolimus in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Blood distribution of rapamycin

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Role of therapeutic drug monitoring of rapamycin

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

An immunoassay for the measurement of sirolimus

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(00)89027-X

7 January 2021

10.1016/S0149-2918(00)89027-X

Identifiers

DOI

1 reference

release_6rsnb63yznc4nknu5ik6puv6oa

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6rsnb63yznc4nknu5ik6puv6oa

24 November 2022

mapped directly with Wikidata item

1 reference